A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials

Abstract

The Institute of Medicine (IOM) has recommended that each person with cancer should have access to clinical trials, which have been associated with improving care quality and disparities. With no effective enrollment monitoring system, patterns of trial enrollment remain unclear